SCHEMBL23713540

SCHEMBL23713540

CCCCCc1ccc(-c2cc3ccc(OCC)cc3oc2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.54
RAB9A P51151 8/20 0.54
MAOB P27338 2/20 0.53
GLA P06280 4/20 0.52
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 3/20 0.52
GAA P10253 3/20 0.52
HPGD P15428 3/20 0.52
HSD17B10 Q99714 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
RECQL P46063 1/20 0.52
ACHE P22303 1/20 0.51
PTPN7 P35236 1/20 0.51
POLB P06746 2/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CYP1A2 P05177 1/20 0.49
CA4 P22748 1/20 0.49
CA6 P23280 1/20 0.49
CA5A P35218 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18535419 0.92 NPC1 (0.55) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL21524274 0.90 NPC1 (0.64) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18583494 0.89 NPC1 (0.50) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18583503 0.89 MAOB (0.52) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18535684 0.88 NPC1 (0.60) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18523589 0.88 MAOB (0.56) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18535597 0.88 MAOB (0.62) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18523600 0.87 MAOB (0.50) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18523586 0.87 MAOB (0.50) NPC1RAB9AMAOBGLAKDM4E
SCHEMBL18535525 0.87 NPC1 (0.48) NPC1RAB9AMAOBGLAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A NPC1 2482/4885RAB9A 930/4885MAOB 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.